Innovative Salivary Gland Biobank Offers Hope for Chronic Dry Mouth Treatment
Mayo Clinic scientists have developed a pioneering biobank of salivary gland tissue-organoids, opening new avenues for regenerating damaged glands and treating chronic dry mouth, especially in cancer patients.
Chronic dry mouth, medically known as xerostomia, affects millions worldwide and is often a debilitating side effect of salivary gland damage. This condition is particularly common among patients who have undergone radiation therapy for head and neck cancers, with nearly 70% experiencing permanent salivary gland damage. The resulting symptoms include difficulty chewing, tasting, speaking, swallowing, and an increased risk of tooth decay, significantly impairing quality of life.
In a groundbreaking development, researchers at Mayo Clinic have established the world’s first biobank of human salivary gland tissue-organoids. This biorepository provides a standardized collection of salivary gland samples, greatly advancing research efforts aimed at regenerating damaged glands and finding effective treatments for dry mouth. According to lead researcher Nagarajan Kannan, Ph.D., this resource addresses a critical barrier in the field—the limited availability of suitable, consistent salivary specimens for regenerative studies.
The biobank comprises samples from 208 donors and has already contributed to identifying biomarkers for saliva-producing cells and mapping the tissue origin of rare, self-renewing salivary cells. This platform enables scientists to develop personalized regenerative therapies, with potential to heal and grow new salivary gland tissue.
Additional research includes creating a radiation injury model to test regenerative approaches and exploring the cellular mechanisms underlying gland repair. This collaborative effort involves several departments at Mayo Clinic, including the Center for Regenerative Biotherapeutics.
The promise of this biobank extends beyond radiation-induced dry mouth, offering hope for patients who suffer from gland damage due to aging, medications, or diseases like diabetes, stroke, Alzheimer’s, and HIV/AIDS. With ongoing discoveries, future therapies may include cultivating regenerative cells and implanting new gland tissue, dramatically improving patient outcomes.
For more insights, refer to the study published in npj Regenerative Medicine: Establishment of salivary tissue-organoid biorepository. Source: https://medicalxpress.com/news/2025-05-salivary-gland-regenerative-biobank-combat.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Electrical Stimulation of Facial Muscles Alters Emotional Perception and Brain Responses
New research reveals that stimulating facial muscles influences how people perceive emotions and alters brain responses, offering insights into social cognition and potential clinical applications.
Revolutionizing the Management of Multiple Sclerosis in Older Adults
Experts call for a major overhaul in managing multiple sclerosis in adults over 50, emphasizing personalized care, improved diagnostics, and inclusive research to adapt to demographic shifts.
Increased Risk of Kidney Disease and Hypertension in Childhood Cancer Survivors: New Findings
Childhood cancer survivors face a higher risk of developing chronic kidney disease and hypertension, emphasizing the need for tailored long-term health monitoring and management strategies.
Raising Awareness About Men's Bone Health and Osteoporosis
June marks Men's Health Awareness Month, highlighting the often overlooked issue of osteoporosis in men. Early prevention, awareness, and treatment are key to maintaining healthy bones and avoiding dangerous fractures.